TNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 With Lymphocyte-depleting Chemotherapy and TILs in the Treatment of Melanoma

NCT06961786 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Melanoma

Interventions

BIOLOGICAL: TILT-123
BIOLOGICAL: TIL
DRUG: Cyclophosphamide
DRUG: Fludarabine

Sponsor

TILT Biotherapeutics Ltd.